SEEBRI NEOHALER (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the SEEBRI NEOHALER drug offered from Novartis Pharmaceuticals Corporation. This Anticholinergic [EPC],Cholinergic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | glycopyrrolate |
| SUBSTANCE NAME: | GLYCOPYRROLATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
| ROUTE: | RESPIRATORY (INHALATION) |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-10-29 |
| END MARKETING DATE: | 0000-00-00 |
SEEBRI NEOHALER HUMAN PRESCRIPTION DRUG Details:
| Item Description | SEEBRI NEOHALER from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15.6(ug/1) |
| START MARKETING DATE: | 2015-10-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0662_447618d2-2930-4167-82f7-e4a6d6ad62bb |
| PRODUCT NDC: | 0078-0662 |
| APPLICATION NUMBER: | NDA207923 |
Other GLYCOPYRROLATE Pharmaceutical Manufacturers / Labelers:
| Manufacturer / Labeler | Proprietary Name |
| American Health Packaging | Glycopyrrolate |
| American Regent, Inc. | Glycopyrrolate |
| Amneal Biosciences | Glycopyrrolate |
| APPCO PHARMA LLCC | Glycopyrrolate |
| Aurolife Pharma, LLC | Glycopyrrolate |
| Avera McKennan Hospital | Glycopyrrolate |
| AvKARE, Inc. | Glycopyrrolate |
| Bryant Ranch Prepack | Glycopyrrolate |
| Cantrell Drug Company | Glycopyrrolate |
| Cardinal Health | Glycopyrrolate |
| Carilion Materials Management | Glycopyrrolate |
| Dr. Reddy’s Laboratories Limited | Glycopyrrolate |
| Excellium Pharmaceutical, Inc. | Glycopyrrolate |
| General Injectables & Vaccines, Inc | Glycopyrrolate |
| Golden State Medical Supply, Inc. | GLYCOPYRROLATE |
| Heritage Pharmaceuticals Inc. | Glycopyrrolate |
| Leading Pharma, LLC | Glycopyrrolate |
| Major Pharmaceuticals | Glycopyrrolate |
| Merz Pharmaceuticals, LLC | Cuvposa |
| Mylan Institutional Inc. | Glycopyrrolate |
| Nexgen Pharma, Inc. | Glycopyrrolate |
| Novartis Pharmaceuticals Corporation | SEEBRI NEOHALER |
| Nuro Pharma, Inc. | Glycate |
| Par Formulations Private Limited | Glycopyrrolate |
| Par Pharmaceutical Inc. | Glycopyrrolate |
| Physicians Total Care, Inc. | GLYCOPYRROLATE |
| Quinn Pharmaceuticals, LLC | GLYCOPYRROLATE |
| Ranbaxy Pharmaceuticals Inc. | Glycopyrrolate |
| Rising Pharmaceuticals, Inc. | Glycopyrrolate |
| Shionogi Inc. | Robinul |
| Somerset Therapeutics, LLC | Glycopyrrolate |
| West-ward Pharmaceutical Corp | Glycopyrrolate |
| West-Ward Pharmaceutical Corp | Glycopyrrolate |
| West-ward Pharmaceutical Corp. | Glycopyrrolate |
